Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
qianliexin
- Development stage
- Unknown
- Lead developer
- Shenyang Pharmaceutical University
- Administration
- Oral
01
Overview
Qianliexin is a Traditional Chinese Medicine (TCM) formulation, commonly produced as capsules, indicated for the treatment of chronic prostatitis and benign prostatic hyperplasia (BPH). The formulation typically includes a combination of herbal ingredients such as *Vaccariae Semen*, *Lycopi Herba*, *Salviae Miltiorrhizae Radix*, and *Persicae Semen*. Its therapeutic mechanism is traditionally characterized by activating blood circulation to dissipate blood stasis and clearing heat and promoting diuresis. In modern pharmacological terms, it is recognized for its anti-inflammatory, analgesic, and microcirculation-improving properties, which help alleviate symptoms like pelvic pain, urinary frequency, and urgency. It is widely used in China and has been the subject of various clinical evaluations, including real-world studies conducted by institutions like Dongzhimen Hospital.
- Brand names
- Qianliexin
- Other names
- Qianliexin capsulesQianliexin jiaonang
02
Targets
NF-κBTNFA (Tumor necrosis factor alpha (soluble))CASP1 (Caspase-1)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)IL1B (Interleukin-1 beta)
Beyond the preview
Go deeper on qianliexin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on qianliexin.